Pilot Study of Continuing Aspirin Versus Switching to Clopidogrel After Stroke or Transient Ischemic Attack

University of California San Diego

Status and phase

Withdrawn

Phase 1

Conditions

Stroke

Clopidogrel

Transient Ischemic Attack

Aspirin

Treatments

Drug: aspirin versus clopidogrel

Study type

Interventional

Funder types

Other

Identifiers

UCSD IRB #060452

Details and patient eligibility

About

Pilot study of continuing aspirin versus switching to clopidogrel after stroke or transient ischemic attack.

Full description

Pilot study of continuing aspirin versus switching to clopidogrel after stroke or transient ischemic attack.

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Age 18 and older.
Stroke or transient ischemic attack (TIA) while taking aspirin within one week of consent.
Women of child-bearing potential will be included only if there is a negative pregnancy test and they agree to birth control during the treatment period.

Exclusion criteria

Any medical indication for a specific antiplatelet agent (aspirin, clopidogrel, ticlopidine, aggrenox), or an indication for a combination of antiplatelet agents.
Any medical indication for anticoagulation, except subcutaneous heparin for deep vein thrombosis prophylaxis.
Allergy to aspirin or clopidogrel.